back to Canada directory
canada clinical guidance

Rosacea: primary care diagnosis and stepwise treatment

A Canadian clinical summary of rosacea: primary care diagnosis and stepwise treatment, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by Canadian Clinical Practice Guidelines for Rosacea. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:Canadian rosacea guideline

Source-attributed clinical priorities

  • Identify erythema, telangiectasia, papules, pustules, phymatous change and ocular symptoms and distinguish acne or steroid dermatitis.
  • Combine trigger and skin-care advice with phenotype-directed topical or oral treatment.
  • Refer ocular pain or visual symptoms, phymatous disease or refractory severe rosacea.
  • Ocular symptoms can occur even when facial skin disease is mild.
sources for this section:Canadian rosacea guideline

Practical assessment and management workflow

1
Identify flushing, persistent erythema, papules, pustules, telangiectasia, phymatous and ocular features.
2
Review heat, alcohol, ultraviolet, skin products and topical-steroid triggers.
3
Use gentle skin care, sun protection and phenotype-directed topical or oral treatment.
4
Review response and refer ocular, phymatous or refractory disease.
sources for this section:Canadian rosacea guideline

Safety, red flags and urgent escalation

  • Eye pain, photophobia or reduced vision requires urgent ophthalmic assessment.
  • Avoid chronic topical corticosteroids on facial rosacea because they can worsen disease.
  • Reconsider lupus, dermatomyositis or infection when morphology or systemic features are atypical.
sources for this section:Canadian rosacea guideline

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:Canadian rosacea guideline

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:Canadian rosacea guideline

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Canadian Rosacea Clinical Practice Guideline PanelCanadian Clinical Practice Guidelines for Rosaceaaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.